Please enable Javascript to get a taste of that HopiumĀ šŸ‘¼

Alexion Pharmaceuticals, Inc

Alexion Pharmaceuticals, Inc

NASDAQ: alxn

$182.41

USD

stock summary arrow

+$0.00

+0.00%

Prev Close

$182.50

Todays Open

$183.08

Avg Vol

0.00

Market Cap

40.34B

Overview

Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases.

Read more
Current Price
15 min delay
Ratios
Valuation Ratios

EPS (TTM)

3.081

P/E Ratio

59.23

Price to Sales

6.47

Price to Book

3.248

Profit Ratios

Profit Margin

10.90%

EBITDA Margin

52.12%

Net Profit Margin

88.10%

ROA

10.10%

Total Revenue

$6.26B

Net Profit

$5.52B

EV to EBITDA

42.56

EV to Revenue

6.32

Interest
Short Interest

Shares Short (Today)

9.80M

Short Previous Month

8.55M

Short % Float

4.44%

Short Interest
Last Month

8.55M

short interest arrow

Up 12.75%

This Month

9.80M

Institutional & Insiders

Institutional Holdings

88.02%

Insider Holdings

0.27%

Holdings Breakdown
Institutional
Insiders
Data source(s): Alpha Vantage